Advanced Search
EurekAlert! Science News A service of the American Association for the Advancement of Science
EurekAlert! Science News A service of the American Association for the Advancement of Science
  • Home
  • News Releases
  • Multimedia
  • Meetings
  • Login
  • Register

Craig Portell, MD (IMAGE)

PrECOG, LLC

Craig Portell, MD

Caption

Craig Portell, MD

Credit

UVA Health

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Media Contact

Diane Dragaud
PrECOG, LLC
ddragaud@ecog-acrin.org
Office: United States
Cell: 202-744-4343



More on this News Release

Venetoclax with standard chemo-immunotherapy induced a high response rate as first-line treatment for mantle cell lymphoma and was generally well tolerated, a PrECOG early-phase trial shows

PrECOG, LLC

Funder
Genentech

Keywords

  • /Health and medicine/Diseases and disorders/Cancer/Lymphoma
  • /Scientific community/Research programs/Cancer research
  • /Life sciences/Organismal biology/Anatomy/Circulatory system/Lymphatic system/Lymph nodes
  • /Life sciences/Cell biology/Cellular physiology/Cell death/Lysis
  • /Health and medicine/Diseases and disorders/Cancer
  • /Scientific community/Research programs/Drug research
  • /Health and medicine/Pharmaceuticals

Original Source

https://www.precogllc.org/news/venetoclax-with-standard-chemo-immunotherapy-induced-a-high-response-rate-as-first-line-treatment-for-mantle-cell-lymphoma-and-was-generally-well-tolerated-a-precog-early-phase-trial-shows

EurekAlert! The Global Source for Science News

AAAS - American Association for the Advancement of Science

Copyright © 2025 by the American Association for the Advancement of Science (AAAS)

  • facebook.com/EurekAlert
  • @EurekAlert
  • youtube.com/EurekAlert

  • Help / FAQ
  • Services
  • Eligibility Guidelines
  • Contact EurekAlert!
  • Terms & Conditions
  • DMCA
  • Privacy Policy
  • Disclaimer

Copyright © 2025 by the American Association for the Advancement of Science (AAAS)